SCHEMBL974861

SCHEMBL974861

CCC(=O)CCC[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5339877 0.91 PTPN7 (0.41)
SCHEMBL8045294 0.91 PTPN7 (0.41)
SCHEMBL6257072 0.91 PTPN7 (0.41)
SCHEMBL8949595 0.84
SCHEMBL19547103 0.83 MAPT (0.46)
SCHEMBL8614496 0.78
SCHEMBL15691473 0.78
SCHEMBL1771453 0.78 TDP1 (0.60)
SCHEMBL12673292 0.78 TDP1 (0.60)
SCHEMBL285143 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8951548-B2 Acrylic hydrogels with pendant cyclodextrins, preparation method thereof and use of same as release systems and contact lens components UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (ES) 2015-02-10 US claimed
EP-1240157-A2 SUBSTITUTED N-BENZYL-INDOL-3-YL GLYOXYLIC ACID DERIVATIVES HAVING AN ANTI-TUMORAL EFFECT Zentaris AG (DE) 2002-09-18 EP claimed
WO-2001047913-A2 SUBSTITUTED N-BENZYL-INDOL-3-YL GLYOXYLIC ACID DERIVATIVES HAVING AN ANTI-TUMORAL EFFECT ZENTARIS AG (DE) 2001-07-05 WO claimed
EP-0001265-A1 O-, N- and carboxyl derivatives of thienamycin sulfoxide and sulfone, their preparation and pharmaceuticals containing said compounds MERCK & CO. INC. (US) 1979-04-04 EP claimed
CN-109280223-B Resin composition and molded article 富士胶片商业创新有限公司 2022-03-08 CN disclosed
US-20200297700-A1 BICYCLIC COMPOUND, PRODUCTION AND USE THEREOF TOBIRA THERAPEUTICS INC (US) 2020-09-24 US disclosed
US-10744132-B2 Sustained-release buprenorphine formulations Alar Pharmaceuticals, Inc. (TW) 2020-08-18 US disclosed
EP-3512518-A1 SUSTAINED-RELEASE BUPRENORPHINE FORMULATIONS BACKGROUND OF INVENTION Alar Pharmaceuticals Inc. (TW) 2019-07-24 EP disclosed
US-20190142823-A1 SUSTAINED-RELEASE BUPRENORPHINE FORMULATIONS Alar Pharmaceuticals, Inc. (TW) 2019-05-16 US disclosed
US-20190038604-A1 BICYCLIC COMPOUND, PRODUCTION AND USE THEREOF TOBIRA THERAPEUTICS, INC. (US) 2019-02-07 US disclosed
WO-2018050043-A1 SUSTAINED-RELEASE BUPRENORPHINE FORMULATIONS BACKGROUND OF INVENTION ALAR PHARMACEUTICALS INC. (CN) 2018-03-22 WO disclosed
EP-2258676-B1 STABLE VINAMIDINIUM SALT AND NITROGEN-CONTAINING HETEROCYCLIC RING SYNTHESIS USING THE SAME TAKEDA PHARMACEUTICAL (JP) 2016-02-17 EP disclosed
US-4459221-A Fluorine-containing surface active composition DAIKIN KOGYO CO., LTD. (JP) 1984-07-10 US disclosed
EP-0043108-A1 Fluorine-containing surface active composition Daikin Kogyo Co., Ltd. (JP) 1982-01-06 EP disclosed
US-4165323-A ANALGESICS, TRANQUILIZERS PFIZER INC. (US) 1979-08-21 US disclosed
EP-0000488-A1 3-Oxaloamino-4-oxo-4H-1-benzopyrane compounds, process for their preparation and their pharmaceutical use CIBA-GEIGY AG (CH) 1979-02-07 EP disclosed
US-4111946-A Preparation of 3-(pyridinyl)-2-cyclohexen-1-ones STERLING DRUG INC. (US) 1978-09-05 US disclosed
US-4041161-A ANTIBIOTICS CIBA-GEIGY CORPORATION (US) 1977-08-09 US disclosed
US-4025316-A POLYMERIC ALKYL HYDROXY BENZYL AMINES, DETERGENTS, ANTIOXIDANTS, GASOLINE, LUBRICATING OIL EXXON RESEARCH AND ENGINEERING COMPANY (US) 1977-05-24 US disclosed
US-4007190-A ANTITUMOR, MICROBIOCIDE MERCK & CO., INC. (US) 1977-02-08 US disclosed